A mouse model for the human lysosomal disease aspartylglycosaminuria

Nature Medicine

Volumn 2, Issue 12, 1996, Pages 1375-1378

  Kaartinen, Vesa ^a,b   Mononen, Ilkka ^c   Voncken, Jan Willem ^a   Noronkoski, Tiina ^c   Gonzalez Gomez, Ignacio ^a   Heisterkamp, Nora ^a   Groffen, John ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTYLGLYCOSAMINURIA; ENZYME DEFICIENCY; LYSOSOME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETYLGLUCOSAMINE; AGE FACTORS; ANIMALS; ASPARTYLGLUCOSYLAMINASE; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; MALE; MICE; MICE, KNOCKOUT; PSYCHOMOTOR PERFORMANCE; RNA, MESSENGER; STEM CELLS; URINARY BLADDER;

ANIMALIA;

EID: 0029850423     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1296-1375     Document Type: Article

References (20)

1. Mononen, I., Fisher, K.J., Kaartinen, V. & Aronson, N.N., Jr. Aspartylglycosaminuria: Protein chemistry and molecular biology of the most common lysosomal storage disorder of glycoprotein degradation. FASEB. J. 7, 1247-1256 (1993).
2. Aula, P., Autio, S., Raivio, K.O. & Rapola, J. Aspartylglucosaminuria. in Genetic Errors of Glycoprotein Metabolism (eds. Durand, P. & O'Brien, J.S.) 123-152 (Springer, Heidelberg, 1982).
3. Thomas, G.H. & Beaudet, A.L. Disorders of glycoprotein degradation and structure: α-Mannosidosis, sialidosis, aspartylglucosaminuria, and carbohydrate-deficient glycoprotein syndrome. in The Metabolic and Molecular Bases of Inherited Disease (eds. Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 2545-2548 (McGraw-Hill, New York, 1995).
4. Tenhunen, K. et al. Molecular cloning, chromosomal assignment, and expression of the mouse aspartylglucosaminidase gene. Genomics 30, 244-250 (1995).
5. Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W. & Roder, J.C. Derivatization of completely cell-culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90, 8424-8428 (1993).
6. Fisher, K.J. & Aronson, N.N., Jr. Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. J. Biol. Chem. 266, 12105-12113 (1991).
7. Kaartinen, V. & Mononen, I. Analysis of aspartylglucosamine at the picomole level by high-performance liquid chromatography. J. Chromatogr. 490, 292-299 (1989).
8. Haltia, M., Palo, J. & Autio, S. Aspartylglucosaminuria: A generalized storage disease. Acta Neuropathol. 31, 243-255 (1975).
9. Arstila, A.U., Palo, J., Haltia, M., Riekkinen, P. & Autio, S. Aspartylglucosaminuria. I. Fine structural studies on liver, kidney and brain. Acta Neuropathol. 20, 207-216 (1972).
10. Otterbach, B. & Stoffel, W. Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Nieman-Pick disease). Cell 81, 1053-1061 (1995).
11. Cases, O. et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268, 1763-1766 (1995).
12. Guastavino, J-M., Larsson, K. & Jaisson, P. Neurological murine mutants as models for single-gene effects on behavior, in Techniques for the Genetic Analysis of Brain and Behavior: Focus on the Mouse, (eds. Goldowitz, G., Wahlsten, D. & Wimer, R.E.) 375-390 (Elsevier, Amsterdam, 1992).
13. Yamazaki, K. et al. Gracile axonal dystrophy (GAD), a new neurological mutant in the mouse. Proc. Soc. Exp. Biol. Med. 187, 209-215 (1988).
14. Indravasu, S. & Dexter, R.A. Infantile neuroaxonal dystrophy and its relationship to Hallervorden-Spatz disease. Neurology 18, 693-699 (1968).
15. Oynagi, K. et al. Galactosialidosis: Neuropathological findings in a case of the late-infantile type. Acta Neuropathol. 85, 331-339 (1991).
16. Mononen, I. et al. Recombinant glycosylasparaginase and in vitro correction of aspartylglycosaminuria. FASEB J. 9, 428-433 (1995).
17. Enomaa, N., Danos, O., Peltonen, I., & Jalanko, A. Correction of deficient enzyme activity in a lysosomal storage disease, aspartylglucosaminuria by enzyme replacement and retroviral gene transfer. Hum. Gene Ther. 6, 723-731 (1995)
18. Wurst, W. & Joyner, A. Production of targeted embryonic stem cell clones, in Gene Targeting: A Practical Approach (ed. Joyner, A.L.) 31-62 (Oxford Univ. Press, Oxford, 1993).
19. Papaioannou, V.P. & Johnson, R. Production of chimeras and genetically defined offspring from targeted ES cells in Gene Targeting: A Practical Approach (ed. Joyner, A.L.) 107-146 (Oxford Univ. Press, Oxford, 1993).
20. Kaartinen, V. & Mononen, I. Assay of aspartylglucosylaminase by high-performance liquid chromatography. Anal. Biochem. 190, 98-101 (1990).